Creative Planning - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 21 filers reported holding ADIAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Creative Planning ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$2,082
-91.3%
10,0000.0%0.00%
Q1 2021$24,00010,0000.00%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Manchester Capital Management LLC 1,202,452$250,3510.03%
COMMONWEALTH EQUITY SERVICES, LLC 36,461$80.00%
Creative Planning 10,000$2,0820.00%
ROYAL BANK OF CANADA 964$00.00%
VANGUARD GROUP INC 203,358$42,3390.00%
TWO SIGMA INVESTMENTS, LP 17,623$3,6690.00%
OSAIC HOLDINGS, INC. 24,046$4,9980.00%
WELLS FARGO & COMPANY/MN 187$390.00%
NORTHERN TRUST CORP 29,705$6,1850.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders